Overview
- Sycamore Partners completed a $10 billion acquisition on August 28, 2025, taking Walgreens Boots Alliance private.
- Shareholders receive $11.45 per share in cash plus a non-transferable right worth up to $3 tied to future monetization of Walgreens' VillageMD interests.
- Sycamore partnered with longtime shareholder Stefano Pessina, who reinvested 100% of his Walgreens Boots Alliance stake.
- Mike Motz, formerly CEO of Staples US Retail and a past president of Shoppers Drug Mart, became chief executive as John Lederer was appointed executive chairman.
- Tim Wentworth stepped down as CEO but remains on the board as Walgreens pivots back to its core pharmacy and retail business after VillageMD-related losses contributed to a fiscal 2024 net loss of more than $8 billion.